Subspecialty in Urology Webinar

USI ISU webinar on subspecialty in Urology will be held on 23rd August 2020.

In India, organised Urology practice started around 1960 by a group of
surgeons interested in Urology. The era between the years 1960-80 was an era of
struggle for Urology, when Urologists had to compete with General Surgeons.The
decades from 1980-2000 saw the stabilisation of Urology as a standalone speciality.
After year 2000, sub-specialisation practice started in Urology and some institutions
started fellowships in Urology.
India is a vast country of 130 billion population and at present, the ratio of
Urologists is 1:5 lac population. Most Urologists are practicing in tier 1 and 2 cities.
The question then arises whether to provide basic Urology care for such a large
population or develop the field further by subspecialisation practice.
There are so many unanswered questions like – Who should do
subspecialisation? In which subspecialty? What should be the duration of
fellowships? When to do subspecialisation? Where to practice after
subspecialisation ? Should work in which city? Should work as solo practice orin
group practice?Should practice in subspeciality alone or combined with Urology
practice? Is subspecialty practice alone financially viable.
We will discuss all these issues as per our survey responses and try to find
answers in our Webinar on 23rd August, 2020 between 10.30am –1.15pm. Please
join.

USICON 2021

Due to COVID pandemic the conference has been shifted to 8th – 11th April’2021

USICON 2021 at Ahmedabad awaits you for an academic feast. Ahmedabad (pronounced as Amdavad in Gujarati) is the largest city and former capital of the Indian state of Gujarat. It is the administrative headquarters of the Ahmadabad district and the seat of the Gujarat High Court. Ahmedabad’s population of 5,633,927 (as per 2011 population census) makes it the fifth-most populous city in India, and the encompassing urban agglomeration population estimated at 6,357,693 is seventh-most populous in India. Ahmadabad is located on the banks of the Sabarmati River, 30 km (19 mi) from the state capital Gandhinagar, which is its twin city.


Ahmedabad has emerged as an important economic and industrial hub in India. It is the second-largest producer of cotton in India, and its stock exchange is the country’s second oldest. Cricket is a popular sport in Ahmedabad, which houses the 54,000-seat Sardar Patel Stadium. The effects of liberalization of the Indian economy have energized the city’s economy towards tertiary sector activities such as commerce, communication, and construction. Ahmedabad’s increasing population has resulted in an increase in the construction and housing industries resulting in the recent development of skyscrapers.

Organising secretariat
Shyam Urosurgical Hospital,
4th-floor, Viva complex,
Opposite Parimal Garden, Ellisbridge,
Ahmedabad- 380006, Gujarat, India,
Ph: 079-26469846, 079- 26466700
Email: usiconaua2021@gmail.com

USI ISU AUA Program

15th August 2020

1630 – 1700 IST

Opening Address : Dr Rajeev Sood, Chairman ISU( 3 mins )
Address by Dr Anant Kumar, President, USI ( 3 mins )
Report by Dr Rajeev T P, Hon Secretary, USI ( 3 mins )
Address by Dr John Denstedt, Secretary, AUA ( 3 mins )
Address by Dr Aseem Shukla ( 3 mins )
Invocation and inauguration ( 5 mins )
Vote of thanks by Dr Arun Chawla, Co Chairman, ISU ( 3 mins )

Session I: Infertility 1700 – 1930 HRS IST
Moderator : Dr S S Vasan

1700 – 1730 IST Penile Implants: What I’ve Learned from 1000 cases – Dr Tobias Kohler
1730 – 1800 IST Supra-physiologic testosterone supplementation: Do body builders know something we don’t? – Dr Tobias Kohler
1800 – 1830 IST Canaries, Giraffes and a little bit of ZEN: Origins and Treatment of ED through vascular mechanisms – – Dr Tobias Kohler
30 – 1900 IST Nothing Beats a TURP? –– Dr Tobias Kohler
1900 – 1920 IST LIVE Q&A via Zoom
1920 – 1930 IST Expert comments :Dr Rupin Shah, Dr Datteswar Hota

Moderator :Dr Anil Takwani
1930 – 2000 IST Antenatal hydronephrosis: A step-wise approach –Dr Aseem Shukla
2000 – 2030 IST Cryptorchidism: What to Do (and not to do)–Dr Aseem Shukla
2030 – 2100 IST The valve bladder syndrome: The end stage of Posterior urethral valves –Dr Aseem Shukla
2100 – 2130 IST UTI and Reflux: A contemporary understanding –Dr Aseem Shukla
2130 – 2150 IST LIVE Q&A via Zoom
Expert comments :Dr M S Ansari, Dr Chandra Singh

16th August 2020

Session Female Urology 1700 – 1945 hrs IST

Moderator : Dr Arun Chawla

1700 – 1730 IST Midurethral Slings – Current Controversies –Dr Priyanka Gupta
1730 – 1800 IST The Pelvic Floor – Anatomy, treatment of pelvic floor dysfunction –Dr Priyanka Gupta
1800 – 1830 IST Evaluation and management of pelvic organ prolapse –Dr Priyanka Gupta
1830 – 1900 IST Voiding Dysfunction –Dr Priyanka Gupta
1900 – 1920 IST LIVE Q&A via Zoom
1920 – 1930 IST Expert comments : Dr Aneesh Srivastava, Dr Sanjay Sinha

Concluding comments :Dr Rajeev T P , Hon Secretary, USI
Dr Aseem Shukla, Assistant Secretary, AUA

Webinar on Testicular and Penile Cancer

The increase in Urologists and centres dedicated to oncology in India in the last decade has been a welcome change. While this is already translating into better clinical and operative management of patients with Urological cancers, it can be further extended to meaningful research eventually contributing to better patient outcome. Globally Penile and Testicular cancer are classified as rare genitourinary cancers. India has a relatively higher incidence of penile cancer compared to that in many other developed nations. Rare cancers suffer from lack of strong evidence in various aspects of its management. One way of generating evidence is to conduct multi institutional studies or collaborative studies. If Indian centres routinely managing these cancers join hands, we would be able to fill the evidence gaps that are glaring at us.

This webinar is an attempt to highlight the missing links in understanding of penile and testicular cancers. Further, USI intends to discuss its vision and the pathways and challenges in conducting national and international collaborative studies which could be very relevant to these cancers. We are fortunate to have the company of three distinguished International faculties with immense experience in translational and clinical research and collaborative studies related to these two cancers.  The increase in Urologists and centres dedicated to oncology in India in the last decade has been a welcome change. While this is already translating into better clinical and operative management of patients with Urological cancers, it can be further extended to meaningful research eventually contributing to better patient outcome. Globally Penile and Testicular cancer are classified as rare genitourinary cancers. India has a relatively higher incidence of penile cancer compared to that in many other developed nations. Rare cancers suffer from lack of strong evidence in various aspects of its management. One way of generating evidence is to conduct multi institutional studies or collaborative studies. If Indian centres routinely managing these cancers join hands, we would be able to fill the evidence gaps that are glaring at us.

This webinar is an attempt to highlight the missing links in understanding of penile and testicular cancers. Further, USI intends to discuss its vision and the pathways and challenges in conducting national and international collaborative studies which could be very relevant to these cancers. We are fortunate to have the company of three distinguished International faculties with immense experience in translational and clinical research and collaborative studies related to these two cancers.